GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC17393 structure
    GC17393Pyridoxine HCl
    CAS: 58-56-0
    Purity: >99.50%

    Pyridoxine HCl (Pyridoxol ؛ فيتامين B6) هو مشتق من البيريدين.

  • GC17416 structure
    GC17416ACHP
    CAS: 406208-42-2
    Purity: >98%

    IκB kinase inhibitor

  • GC17510 structure
    GC17510Compstatin control peptide
    CAS: 301544-78-5
    Purity: >98%

    ببتيد التحكم كومبستاتين هو عنصر تحكم سلبي في كومبستاتين

  • GC17532 structure
    GC17532Pertussis Toxin
    CAS: 70323-44-3
    Purity: >95.00%

    دراسة إشارات مستقبلات البروتين المقترنة بـ G في الخلايا

  • GC17574 structure
    GC17574BAPTA
    CAS: 85233-19-8
    Purity: >98.00%

    BAPTA هو مخلب انتقائي للكالسيوم

  • GC17603 structure
    GC17603PS-1145
    CAS: 431898-65-6
    Purity: >99.50%

    PS-1145 هو مثبط IκB كيناز (IKK) مع IC50 من 88 نانومتر

  • GC17608 structure
    GC17608Lidocaine
    CAS: 137-58-6
    Purity: >99.50%

    يثبط ليدوكائين (Lignocaine) قنوات الصوديوم التي تنطوي على جهد معقد واستخدام الاعتماد

  • GC17632 structure
    GC17632Maslinic Acid
    CAS: 4373-41-5
    Purity: >98.00%

    يمكن لحمض Maslinic أن يثبط نشاط ربط الحمض النووي لـ NF-κB p65 وإلغاء الفسفرة لـ IκB-α ، وهو أمر مطلوب لتنشيط p65

  • GC17659 structure
    GC17659AS 101
    CAS: 106566-58-9
    Purity: >98.00%

    AS 101 (AS101) ، مركب تيلوريوم مناعي ، هو IL-1β ؛ المانع.

  • GC17707 structure
    GC17707Bismuth Subsalicylate
    CAS: 14882-18-9
    Purity: >97.00%

    البزموت سبساليسيلات هو عامل فعال ومضاد للحموضة عن طريق الفم ومضاد للإسهال

  • GC17718 structure
    GC17718Muscone
    CAS: 541-91-3
    Purity: >98.00%

    المسكون هو المونومر النشط الرئيسي لمسك الطب الصيني التقليدي

  • GC17873 structure
    GC17873CID-2858522
    CAS: 758679-97-9
    Purity: >98%

    A selective inhibitor of NF-κB activation

  • GC17951 structure
    GC179512-TEDC
    CAS: 132465-10-2
    Purity: >98%

    5-, 12-, and 15-lipoxygenase inhibitor

  • GC17961 structure
    GC17961Suplatast Tosylate
    CAS: 94055-76-2
    Purity: >99.00%

    Suplatast Tosilate (IPD 1151T) هو مثبط خلوي Th2 نشط عن طريق الفم والذي يمكن أن يثبط إنتاج IL-4 و IL-5 من خلايا Th2 ويثبط تخليق IgE.

  • GC17963 structure
    GC17963CHPG Sodium salt
    CAS: 1303993-73-8
    Purity: >99.50%

    ملح الصوديوم CHPG هو ناهض mGluR5 انتقائي ، ويخفف الإجهاد التأكسدي الناجم عن SO2 والالتهاب من خلال مسار TSG-6 / NF-κB في خلايا BV2 الدبقية الصغيرة

  • GC17995 structure
    GC17995Tacrolimus monohydrate
    CAS: 109581-93-3
    Purity: >99.90%

    Tacrolimus monohydrate (FK506 monohydrate) ، وهو لاكتون كبير الحلقي ، يرتبط ببروتين رابط FK506 (FKBP) ليشكل مركبًا ويثبط إنزيم فوسفاتاز الكالسينورين ، الذي يثبط نقل إشارة الخلايا اللمفاوية التائية ونسخ IL-2

  • GC17996 structure
    GC17996Toll-like receptor modulator
    CAS: 926927-42-6
    Purity: >99.00%
  • GC18042 structure
    GC18042Isoprinosine
    CAS: 36703-88-5
    Purity: >99.50%

    Isoprinosine هو مركب قوي مضاد للفيروسات واسع الطيف لعدوى فيروس نقص المناعة البشرية.

  • GC18046 structure
    GC18046Erdosteine
    CAS: 84611-23-4
    Purity: >99.50%

    يثبط Erdosteine تنشيط NF-B الناجم عن عديد السكاريد الدهني

  • GC18069 structure
    GC18069Cardamonin
    CAS: 19309-14-9
    Purity: >98.00%

    Cardamonin ((E) -Cardamomin) هو مضاد جديد لقناة الكاتيون hTRPA1 مع IC50 من 454 نانومتر.

  • GC18071 structure
    GC18071CORM-3
    CAS: 475473-26-8
    Purity: >98.00%

    يعرض تأثيرات مضادة للالتهابات / حماية القلب.

  • GC18126 structure
    GC18126Balsalazide
    CAS: 80573-04-2
    Purity: >99.00%

    يمكن للسالازيد أن يثبط التسرطن المرتبط بالتهاب القولون من خلال تعديل مسار IL-6 / STAT3

  • GC18180 structure
    GC18180KRN 7000
    CAS: 158021-47-7
    Purity: >98.00%

    KRN 7000 (ألفا-جالسير) هو جلايكوليبيد اصطناعي له خصائص مضادة للأورام ومحفزة للجهاز المناعي.

  • GC18181 structure
    GC18181GW 405833
    CAS: 180002-83-9
    Purity: >98%

    GW 405833 (L768242) هو ناهض قوي وانتقائي لمستقبلات القنب 2 (CB2) مع EC50 يبلغ 50.7 نانومتر.